Marketable Securities, Current in USD of EXACT SCIENCES CORP from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
EXACT SCIENCES CORP quarterly Marketable Securities, Current history and change rate from Q4 2010 to Q3 2025.
  • EXACT SCIENCES CORP Marketable Securities, Current for the quarter ending 30 Sep 2025 was $214M, a 50.5% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

EXACT SCIENCES CORP Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $214M -$218M -50.5% 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 $201M -$215M -51.7% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $439M +$134M +44.1% 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $437M +$265M +154% 31 Dec 2024 10-Q 03 Nov 2025
Q3 2024 $432M +$293M +209% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $417M +$245M +143% 30 Jun 2024 10-Q 31 Jul 2024
Q1 2024 $305M +$27.3M +9.85% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $172M -$217M -55.8% 31 Dec 2023 10-K 19 Feb 2025
Q3 2023 $140M -$294M -67.8% 30 Sep 2023 10-Q 01 Nov 2023
Q2 2023 $171M -$343M -66.7% 30 Jun 2023 10-Q 01 Aug 2023
Q1 2023 $277M -$350M -55.8% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $390M -$325M -45.5% 31 Dec 2022 10-K 21 Feb 2024
Q3 2022 $434M -$511M -54.1% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $515M -$429M -45.5% 30 Jun 2022 10-Q 02 Aug 2022
Q1 2022 $627M +$353M +129% 31 Mar 2022 10-Q 26 Apr 2022
Q4 2021 $715M +$366M +105% 31 Dec 2021 10-K 21 Feb 2023
Q3 2021 $945M +$468M +98.3% 30 Sep 2021 10-Q 02 Nov 2021
Q2 2021 $944M +$425M +82% 30 Jun 2021 10-Q 28 Jul 2021
Q1 2021 $274M -$256M -48.3% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 $349M +$202M +138% 31 Dec 2020 10-K 22 Feb 2022
Q3 2020 $476M +$350M +277% 30 Sep 2020 10-Q 27 Oct 2020
Q2 2020 $519M -$516M -49.9% 30 Jun 2020 10-Q 31 Jul 2020
Q1 2020 $530M -$467M -46.9% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $146M -$817M -84.8% 31 Dec 2019 10-K 16 Feb 2021
Q3 2019 $126M -$897M -87.7% 30 Sep 2019 10-Q 29 Oct 2019
Q2 2019 $1.03B +$37.9M +3.8% 30 Jun 2019 10-Q 30 Jul 2019
Q1 2019 $998M +$104M +11.6% 31 Mar 2019 10-Q 30 Apr 2019
Q4 2018 $964M +$617M +178% 31 Dec 2018 10-K 21 Feb 2020
Q3 2018 $1.02B +$612M +149% 30 Sep 2018 10-Q 30 Oct 2018
Q2 2018 $997M +$693M +228% 30 Jun 2018 10-Q 01 Aug 2018
Q1 2018 $893M +$658M +279% 31 Mar 2018 10-Q 26 Apr 2018
Q4 2017 $347M +$85M +32.4% 31 Dec 2017 10-K 21 Feb 2019
Q3 2017 $412M +$137M +50% 30 Sep 2017 10-Q 30 Oct 2017
Q2 2017 $304M +$129M +73.6% 30 Jun 2017 10-Q 25 Jul 2017
Q1 2017 $235M +$25M +11.9% 31 Mar 2017 10-Q 27 Apr 2017
Q4 2016 $262M -$3.57M -1.34% 31 Dec 2016 10-K 22 Feb 2018
Q3 2016 $274M -$37.6M -12.1% 30 Sep 2016 10-Q 26 Oct 2016
Q2 2016 $175M -$1.99M -1.12% 30 Jun 2016 10-Q 26 Jul 2016
Q1 2016 $210M +$5.97M +2.92% 31 Mar 2016 10-Q 03 May 2016
Q4 2015 $266M +$41.1M +18.3% 31 Dec 2015 10-K 21 Feb 2017
Q3 2015 $312M +$129M +70.2% 30 Sep 2015 10-Q 30 Oct 2015
Q2 2015 $177M -$37M -17.3% 30 Jun 2015 10-Q 31 Jul 2015
Q1 2015 $204M +$106M +108% 31 Mar 2015 10-Q 04 May 2015
Q4 2014 $225M +$104M +86.6% 31 Dec 2014 10-K 24 Feb 2016
Q3 2014 $183M +$45.2M +32.7% 30 Sep 2014 10-Q 31 Oct 2014
Q2 2014 $214M +$77.9M +57.2% 30 Jun 2014 10-Q 01 Aug 2014
Q1 2014 $98.2M +$10.8M +12.3% 31 Mar 2014 10-Q 02 May 2014
Q4 2013 $120M +$25.6M +27% 31 Dec 2013 10-K 27 Feb 2015
Q3 2013 $138M +$32.2M +30.4% 30 Sep 2013 10-Q 01 Nov 2013
Q2 2013 $136M +$71.4M +110% 30 Jun 2013 10-Q 02 Aug 2013
Q1 2013 $87.4M +$16.2M +22.7% 31 Mar 2013 10-Q 03 May 2013
Q4 2012 $94.8M +$37.2M +64.6% 31 Dec 2012 10-K 28 Feb 2014
Q3 2012 $106M +$35.5M +50.4% 30 Sep 2012 10-Q 02 Nov 2012
Q2 2012 $64.8M +$19.6M +43.4% 30 Jun 2012 10-Q 26 Jul 2012
Q1 2012 $71.2M 31 Mar 2012 10-Q 04 May 2012
Q4 2011 $57.6M +$40.9M +246% 31 Dec 2011 10-K 01 Mar 2013
Q3 2011 $70.4M 30 Sep 2011 10-Q 04 Nov 2011
Q2 2011 $45.2M 30 Jun 2011 10-Q 05 Aug 2011
Q4 2010 $16.7M 31 Dec 2010 10-K 09 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.